Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers

H. Yeh, Sylvia; Gurtman, Alejandra; Hurley, David; L. Block, Stan; H. Schwartz, Richard; D. Patterson, Scott; U. Jansen, Kathrin; Love, Jack; C. Gruber, William; A. Emini, Emilio; A. Scott, Daniel; behalf of the 004 Study Group, on

doi:10.1542/peds.2009-3027

Public

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers

Published in PEDIATRICS • Aug 24, 2010

Authors:

Sylvia H. Yeh

Alejandra Gurtman

David Hurley

Abstract

BACKGROUND: 7-Valent pneumococcal conjugate vaccine (PCV7 [Prevnar, Wyeth Pharmaceuticals Inc, Philadelphia, PA], serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) is effective in preventing vaccine-serotype pneumococcal disease. 13-Valent pneumococcal conjugate vaccine (PCV13) (PCV7 serotypes plus 1, 3, ...

Subject

Pneumococcal conjugate vaccine

Reactogenicity

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!